MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays

International Journal of Cancer

Volumn 133, Issue 4, 2013, Pages 920-928

  Steurer, Stefan ^a   Borkowski, Carina ^a   Odinga, Sinje ^a   Buchholz, Malte ^a   Koop, Christina ^a   Huland, Hartwig ^a   Becker, Michael ^b   Witt, Matthias ^b   Trede, Dennis ^c   Omidi, Maryam ^a   Kraus, Olga ^a   Bahar, Ahmad S ^a   Seddiqi, A Shoaib ^a   Singer, Julius M ^a   Kwiatkowski, Marcel ^a   Trusch, Maria ^d   Simon, Ronald ^a   Wurlitzer, Marcus ^a   Minner, Sarah ^a   Schlomm, Thorsten ^a   Sauter, Guido ^a   Schlüter, Hartmut ^a   more..

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BRUKER DALTONIK GMBH   (Germany)

^c Steinbeis Innovation Center for Scientific Computing in Life Sciences (SCiLS)   (Germany)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

antigen retrieval; ERG; formalin fixed tissue; Ki67; MALDI imaging; prognosis; prostate cancer; tissue microarray

Indexed keywords

FORMALDEHYDE; KI 67 ANTIGEN; PARAFFIN; PROSTATE SPECIFIC ANTIGEN; SERINE PROTEINASE; TRANSCRIPTION FACTOR ERG;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; EMBEDDING; FOLLOW UP; GENE FUSION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; SIGNAL TRANSDUCTION;

AGED; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TISSUE ARRAY ANALYSIS;

EID: 84878844720     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28080     Document Type: Article

References (46)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
2. Ryan CJ, Elkin EP, Cowan J, et al. Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURE. Cancer 2007; 110: 81-6. (Pubitemid 46986421)
3. Taylor BS, Schultz N, Hieronymus H, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010; 18: 11-22.
4. Markert EK, Mizuno H, Vazquez A, et al. Molecular classification of prostate cancer using curated expression signatures. Proc Natl Acad Sci USA 2011; 108: 21276-81.
5. Grubb RL, Deng J, Pinto PA, et al. Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures. J Proteome Res 2009; 8: 3044-54.
6. Schwamborn K, Caprioli RM,. MALDI imaging mass spectrometry-painting molecular pictures. Mol Oncol 2010; 4: 529-38.
7. Groseclose MR, Massion PP, Chaurand P, et al. High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics 2008; 8: 3715-24.
8. Casadonte R, Caprioli RM,. Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry. Nat Protoc 2011; 6: 1695-709.
9. Minner S, Jessen B, Stiedenroth L, et al. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer. Clin Cancer Res 2010; 16: 1553-60.
10. Minner S, Enodien M, Sirma H, et al. ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy. Clin Cancer Res 2011; 17: 5878-88.
11. Wisztorski M, Franck J, Salzet M, Fournier I,. MALDI direct analysis and imaging of frozen versus FFPE tissues: what strategy for which sample? Methods Mol Biol 2010; 656: 303-22.
12. Holle A, Haase A, Kayser M, et al. Optimizing UV laser focus profiles for improved MALDI performance. J Mass Spectrom 2006; 41: 705-16. (Pubitemid 44023098)
13. Yamada M, Yao I, Hayasaka T, et al. Identification of oligosaccharides from histopathological sections by MALDI imaging mass spectrometry. Anal Bioanal Chem 2012; 402: 1921-30.
14. Han B, Mehra R, Lonigro RJ, et al. Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression. Mod Pathol 2009; 22: 1083-93.
15. Yoshimoto M, Joshua AM, Cunha IW, et al. Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome. Mod Pathol 2008; 21: 1451-60.
16. King JC, Xu J, Wongvipat J, et al. Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis. Nat Genet 2009; 41: 524-6.
17. Carver BS, Tran J, Gopalan A, et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet 2009; 41: 619-24.
18. Lapointe J, Li C, Giacomini CP, et al. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. Cancer Res 2007; 67: 8504-10. (Pubitemid 47437424)
19. Di Modugno F, Bronzi G, Scanlan MJ, et al. Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response. Int J Cancer 2004; 109: 909-18. (Pubitemid 38500748)
20. Goicoechea SM, Bednarski B, Garcia-Mata R, et al. Palladin contributes to invasive motility in human breast cancer cells. Oncogene 2009; 28: 587-98.
21. Lin C, Yang L, Tanasa B, et al. Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 2009; 139: 1069-83.
22. Schlomm T, Iwers L, Kirstein P, et al. Clinical significance of p53 alterations in surgically treated prostate cancers. Mod Pathol 2008; 21: 1371-79.
23. Schlomm T, Kirstein P, Iwers L, et al. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer. Clin Cancer Res 2007; 13(22 Part 1): 6579-84. (Pubitemid 350206791)
24. Fleischmann A, Schlomm T, Huland H, et al. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients. Clin Cancer Res 2008; 14: 7838-42.
25. Minner S, Wittmer C, Graefen M, et al. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer. Prostate 2011; 71: 281-8.
26. El Gammal AT, Bruchmann M, Zustin J, et al. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer. Clin Cancer Res 2010; 16: 56-64.
27. Rauser S, Marquardt C, Balluff B, et al. Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. J Proteome Res 2010; 9: 1854-63.
28. Balluff B, Elsner M, Kowarsch A, et al. Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier. J Proteome Res 2010; 9: 6317-22.
29. Cazares LH, Troyer D, Mendrinos S, et al. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue. Clin Cancer Res 2009; 15: 5541-51.
30. Masterson TA, Dill AL, Eberlin LS, et al. Distinctive glycerophospholipid profiles of human seminoma and adjacent normal tissues by desorption electrospray ionization imaging mass spectrometry. J Am Soc Mass Spectrom 2011; 22: 1326-33.
31. Schwamborn K, Krieg RC, Reska M, et al. Identifying prostate carcinoma by MALDI-Imaging. Int J Mol Med 2007; 20: 155-9.
32. Le Faouder J, Laouirem S, Chapelle M, et al. Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis. J Proteome Res 2011; 10: 3755-65.
33. Shimma S, Sugiura Y, Hayasaka T, et al. MALDI-based imaging mass spectrometry revealed abnormal distribution of phospholipids in colon cancer liver metastasis. J Chromatogr B 2007; 855: 98-103. (Pubitemid 47077722)
34. Oezdemir RF, Gaisa NT, Lindemann-Docter K, et al. Proteomic tissue profiling for the improvement of grading of noninvasive papillary urothelial neoplasia. Clin Biochem 2012; 45: 7-11.
35. Cheng CC, Chang J, Chen LY, et al. Human neutrophil peptides 1-3 as gastric cancer tissue markers measured by MALDI-imaging mass spectrometry: implications for infiltrated neutrophils as a tumor target. Dis Markers 2012; 32: 21-31.
36. Kubo A, Ohmura M, Wakui M, et al. Semi-quantitative analyses of metabolic systems of human colon cancer metastatic xenografts in livers of superimmunodeficient NOG mice. Anal Bioanal Chem 2011; 400: 1895-904.
37. Lee GK, Lee HS, Park YS, et al. Lipid MALDI profile classifies non-small cell lung cancers according to the histologic type. Lung Cancer 2012; 76: 197-203.
38. Veloso A, Astigarraga E, Barreda-Gomez G, et al. Anatomical distribution of lipids in human brain cortex by imaging mass spectrometry. J Am Soc Mass Spectrom 2011; 22: 329-38.
39. Gutierrez DB, Garland D, Schey KL,. Spatial analysis of human lens aquaporin-0 post-translational modifications by MALDI mass spectrometry tissue profiling. Exp Eye Res 2011; 93: 912-20.
40. Grey AC, Schey KL,. Age-related changes in the spatial distribution of human lens alpha-crystallin products by MALDI imaging mass spectrometry. Investig Ophthalmol Visual Sci 2009; 50: 4319-29.
41. Andersson M, Groseclose MR, Deutch AY, et al. Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction. Nat Methods 2008; 5: 101-8.
42. Walch A, Rauser S, Deininger SO, et al. MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology. Histochem Cell Biol 2008; 130: 421-34.
43. Aerni HR, Cornett DS, Caprioli RM,. High-throughput profiling of formalin-fixed paraffin-embedded tissue using parallel electrophoresis and matrix-assisted laser desorption ionization mass spectrometry. Anal Chem 2009; 81: 7490-5.
44. Gustafsson JO, Oehler MK, McColl SR, et al. Citric acid antigen retrieval (CAAR) for tryptic peptide imaging directly on archived formalin-fixed paraffin-embedded tissue. J Proteome Res 2010; 9: 4315-28.
45. Lazova R, Seeley EH, Keenan M, et al. Imaging mass spectrometry-a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas. Am J Dermatopathol 2012; 34: 82-90.
46. Djidja MC, Claude E, Snel MF, et al. MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections. J Proteome Res 2009; 8: 4876-84.